RPA3 Antibody

What is RPA3 and what is its biological function?

RPA3 (also known as RPA14, Replication Protein A 14 kDa subunit) is the smallest subunit of the heterotrimeric replication protein A complex (RPA/RP-A), which also includes RPA1 (70 kDa) and RPA2 (32 kDa) subunits . As part of this complex, RPA3 binds and stabilizes single-stranded DNA intermediates that form during DNA replication or upon DNA stress . It prevents reannealing of DNA while recruiting and activating proteins involved in DNA metabolism . RPA3 has its own single-stranded DNA-binding activity and may be responsible for determining the polarity of the complex's binding to DNA . The RPA complex plays essential roles in both DNA replication and cellular responses to DNA damage, including DNA repair and checkpoint activation .

How does RPA3 contribute to DNA repair mechanisms?

RPA3, as part of the RPA complex, contributes to multiple DNA repair pathways:

• Double-strand break repair: RPA3 is required for the recruitment of repair factors RAD51 and RAD52 to chromatin in response to DNA damage . This facilitates homologous recombination repair.

• Nucleotide excision repair (NER): RPA3 helps recruit proteins like XPA and XPG to sites of DNA damage .

• Base excision repair (BER): The RPA complex plays a role in BER, likely through interaction with UNG (uracil-DNA glycosylase) .

• DNA damage checkpoint activation: Through recruitment of ATRIP, RPA activates the ATR kinase, a master regulator of DNA damage response .

• Replication fork restart: RPA recruits SMARCAL1/HARP, which is involved in replication fork restart, to sites of DNA damage .

What criteria should guide selection of an appropriate RPA3 antibody?

When selecting an RPA3 antibody for research, consider these critical factors:

Available RPA3 antibodies include mouse polyclonal antibodies (e.g., ab167593) validated for Western blot and immunofluorescence applications , and rabbit polyclonal antibodies (e.g., 10692-1-AP) validated for Western blot and immunohistochemistry .

How can I validate the specificity of an RPA3 antibody in my experimental system?

Rigorous validation ensures reliable experimental results:

• Positive controls: Use cell lines with known RPA3 expression (K-562, Jurkat, A549, HeLa, HepG2) .

• Molecular weight verification: Confirm detection at the expected 14 kDa band .

• Overexpression validation: Compare antibody detection in RPA3-transfected cells versus non-transfected controls . Western blot data shows distinct bands between RPA3-transfected 293T cells compared to non-transfected controls .

• Knockout/knockdown controls: Use CRISPR-based RPA3 knockout or siRNA knockdown cells as negative controls .

• Cross-reactivity assessment: Test for non-specific binding to related proteins, particularly RPA1 and RPA2.

What are optimal conditions for Western blot detection of RPA3?

For successful Western blot detection of RPA3:

• Sample preparation: Prepare whole cell lysates using RIPA buffer with protease inhibitors.

• Gel percentage: Use 12-15% gels for optimal resolution of the small (14 kDa) RPA3 protein.

• Protein loading: Load 15 μL of cell lysate per lane (based on protocol for ab167593) .

• Primary antibody dilution:

  • Mouse polyclonal (ab167593): 1 μg/mL

  • Rabbit polyclonal (10692-1-AP): 1:500-1:2000

• Secondary antibody:

  • For mouse primary: Anti-mouse IgG-HRP at 1:2500

  • For rabbit primary: Anti-rabbit IgG-HRP at appropriate dilution

• Expected results: 14-16 kDa band, with potential variation in intensity across cell lines .

How should immunofluorescence experiments be optimized for RPA3 detection?

For optimal immunofluorescence detection of RPA3:

• Cell fixation and permeabilization: Fix cells with appropriate fixative (paraformaldehyde recommended).

• Antibody dilution: For ab167593, use at 10 μg/mL for immunofluorescence in HeLa cells .

• Secondary antibody: Use fluorescently-labeled secondary antibodies appropriate for your primary antibody (e.g., anti-mouse Alexa 488) .

• Nuclear counterstain: DAPI is recommended for nuclear visualization .

• Mounting: Use anti-fade mounting medium to preserve fluorescence .

• Expected pattern: RPA3 shows primarily nuclear localization with potential foci formation after DNA damage .

What are the key considerations for using RPA3 antibodies in immunohistochemistry?

For successful immunohistochemical detection of RPA3:

• Antigen retrieval: TE buffer pH 9.0 is suggested as primary option, with citrate buffer pH 6.0 as an alternative .

• Antibody dilution: For rabbit polyclonal (10692-1-AP), use 1:750-1:3000 dilution .

• Positive control tissues: Human lung cancer tissue has been validated for RPA3 detection .

• Detection system: Choose appropriate secondary antibody and visualization system based on your primary antibody.

• Optimization: Antibody concentration should be titrated for each testing system to obtain optimal results .

How can RPA3 antibodies be used to study DNA repair kinetics?

RPA3 antibodies enable quantitative assessment of DNA repair through various approaches:

• Foci formation assays:

  • Induce DNA damage with radiation or chemical agents

  • Perform immunofluorescence for RPA3 at different timepoints

  • Quantify cells with RPA3 foci (similar to γH2AX foci quantification)

  • Compare kinetics of foci resolution between different cell types or treatments

• Co-localization studies:

  • Perform double immunofluorescence with RPA3 and other repair factors like RAD51

  • Use mouse polyclonal antibody against RPA3 (ab167593) and rabbit monoclonal antibody against RAD51 (ab133534)

  • Analyze co-localization at damage sites using confocal microscopy

  • Consider cells with more than five RAD51 foci as RAD51 foci-positive cells

• Chromatin fractionation:

  • Isolate chromatin-bound proteins after DNA damage

  • Perform Western blotting for RPA3

  • Quantify RPA3 recruitment to chromatin over time

What is the relationship between RPA3 expression and cancer radioresistance?

RPA3 has emerged as a potential marker of radioresistance in cancer, particularly nasopharyngeal carcinoma (NPC):

How does RPA3 interact with other proteins in the DNA damage response pathway?

RPA3 engages in critical protein-protein interactions during DNA damage response:

• Interactions with repair factors:

  • RPA3, as part of the RPA complex, interacts with RAD51 and RAD52 to facilitate homologous recombination repair

  • It also interacts with XPA and XPG for nucleotide excision repair

  • UNG interaction mediates base excision repair

• E3 ligase interactions:

  • RFWD3, a RING finger-type E3 ubiquitin ligase, interacts with the RPA complex through RPA32 (RPA2)

  • This interaction is enhanced following DNA damage (e.g., mitomycin C treatment)

  • RFWD3 promotes ubiquitylation of all three RPA subunits, including RPA14 (RPA3)

• Studying these interactions:

  • Co-immunoprecipitation experiments can detect RPA3 interactions

  • Using catalytically inactive RFWD3 (C315A) can stabilize and enhance detection of RPA-RFWD3 interactions

  • DNA-damaging agents can increase the detection of certain interactions in a dose-dependent manner

What are common challenges when working with RPA3 antibodies and how can they be addressed?

Common challenges and solutions when working with RPA3 antibodies:

How can RPA3 antibodies be integrated with other techniques for comprehensive DNA repair studies?

Integrated approaches using RPA3 antibodies:

• ChIP-seq analysis:

  • Perform chromatin immunoprecipitation with RPA3 antibodies

  • Sequence precipitated DNA to identify RPA3 binding sites genome-wide

  • Map RPA3 binding to regions of DNA damage or replication stress

• Proximity ligation assay (PLA):

  • Detect protein-protein interactions between RPA3 and other repair factors

  • Visualize interactions in situ with single-molecule resolution

  • Quantify interaction dynamics following DNA damage

• Live-cell imaging:

  • Generate fluorescent protein-tagged RPA3 constructs

  • Validate with antibody staining in fixed cells

  • Track RPA3 recruitment to damage sites in real-time

• DNA fiber analysis with immunodetection:

  • Label nascent DNA to visualize replication

  • Perform immunostaining for RPA3 to correlate with replication stress sites

  • Analyze the relationship between RPA3 and replication fork dynamics

• CRISPR screening with RPA3 readouts:

  • Use CRISPR libraries to identify genes affecting DNA repair

  • Measure RPA3 foci formation as a phenotypic readout

  • Identify novel regulators of RPA3 function in repair pathways

What considerations are important when using RPA3 antibodies in multiplexed imaging approaches?

For multiplexed imaging with RPA3 antibodies:

• Antibody compatibility:

  • Select RPA3 antibodies raised in different host species than other target antibodies

  • For example, use mouse anti-RPA3 (ab167593) with rabbit anti-RAD51 (ab133534)

• Fluorophore selection:

  • Choose fluorophores with minimal spectral overlap

  • Consider sequential staining for closely overlapping spectra

  • Example: anti-mouse Alexa 488 for RPA3 and anti-rabbit Alexa 546 for RAD51

• Controls for multiplexed imaging:

  • Include single-stained controls for each antibody

  • Perform secondary-only controls to assess non-specific binding

  • Use known patterns of co-localization as positive controls

• Analysis considerations:

  • Use appropriate co-localization metrics (Pearson's coefficient, Manders' overlap)

  • Consider 3D analysis for nuclear proteins like RPA3

  • Quantify foci using consistent criteria (e.g., cells with >20 γH2AX foci considered positive)